Marine-Inspired Regenerative Strategies for Chronic Diseases
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (20 January 2022) | Viewed by 3824
Special Issue Editors
Interests: stem cell biology; regenerative medicine; osteoarthritis; chronic degenerative diseases
Interests: stem cell biology; regenerative medicine; osteoarthritis; chronic degenerative diseases
Special Issue Information
Dear Colleagues,
Chronic diseases of the musculoskeletal system are one of the primary causes of disability worldwide and often lack effective pharmacological treatments. The regenerative approach to restoring organ function aims to re-establish physiological conditions to act on local or implanted progenitor cells. Tissue regeneration is achieved through the administration of stem/progenitor cells, their differentiated progeny or, in some cases, secretomes. Local or systemic treatment is possible with stimulation through small molecules or growth factors and the use of biomaterials such as biopolymers or ceramics. However, current strategies do not sufficiently address clinical needs and there is an urgent need for the discovery of new bioactive compounds or biomaterials to efficiently stimulate stem cell activities. The ocean is the most extensive and the least studied environment on Earth, hosting huge biodiversity, chemodiversity and potential for drug discovery. Research of bioactive marine compounds for regenerative medicine has great potential to contribute to the development of novel treatments for painful conditions affecting millions of people worldwide.
Prof. Dr. Mary Murphy
Dr. Pietro Marchese
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Marine natural products
- Regenerative medicine
- Tissue engineering
- Stem cells
- Stem cell differentiation
- High throughput screening
- Chronic diseases
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
